CERS4 predicts positive anti-PD-1 response and promotes immunomodulation through Rhob-mediated suppression of CD8+Tim3+ exhausted T cells in non-small cell lung cancer-Reference-Cited by-同舟云学术

CERS4 predicts positive anti-PD-1 response and promotes immunomodulation through Rhob-mediated suppression of CD8+Tim3+ exhausted T cells in non-small cell lung cancer

Published:2023-08 Issue: Volume:194 Page:106850
ISSN:1043-6618
Container-title:Pharmacological Research
language:en
Short-container-title:Pharmacological Research

Author:

Wang Jian,Li Run-Ze,Wang Wen-Jun,Pan Hu-Dan,Xie Chun,Yau Lee-Fong,Wang Xing-Xia,Long Wei-Li,Chen Rui-Hong,Liang Tu-Liang,Ma Lin-Rui,Li Jia-Xin,Huang Ju-Min,Wu Qi-Biao,Liu Liang,He Jian-Xing,Leung Elaine Lai-Han

Publisher

Elsevier BV

Subject

Pharmacology

Reference56 articles.

1. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA a Cancer J. Clin.,2021

2. The effect of advances in lung-cancer treatment on population mortality;Howlader;N. Engl. J. Med,2020

3. Update of incidence, prevalence, survival, and initial treatment in patients with non-small cell lung cancer in the US;Ganti;JAMA Oncol.,2021

4. Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up;Planchard;Ann. Oncol.,2018

5. 97O First-line pembrolizumab plus chemotherapy for patients with advanced squamous NSCLC: 3-year follow-up from KEYNOTE-407;Robinson;J. Thorac. Oncol.,2021

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Peripheral Blood Biomarkers Predicting the Efficacy of Immune Checkpoint Inhibitors in Non-small Cell Lung Cancer: A Retrospective Study;2024-07-02

2. Ceramides and mitochondrial homeostasis;Cellular Signalling;2024-05

3. Cordyceps sinensis relieves non-small cell lung cancer by inhibiting the MAPK pathway;Chinese Medicine;2024-03-25

4. Predictive impact of sarcopenia in advanced non-small cell lung cancer patients treated with immune checkpoint inhibitors: A retrospective study;Heliyon;2024-03

5. Machine learning-enhanced insights into sphingolipid-based prognostication: revealing the immunological landscape and predictive proficiency for immunomotherapy and chemotherapy responses in pancreatic carcinoma;Frontiers in Molecular Biosciences;2023-10-31